By Dr Sunil Badve

Book Chapters

Jefferis JM; Johnson DW; Badve S, 2023, 'Hyperuricaemia and Chronic Kidney Disease', in Management of Chronic Kidney Disease A Clinicians Guide Second Edition, pp. 81 - 97, http://dx.doi.org/10.1007/978-3-031-42045-0_7

O'Shea S; Badve SV; Johnson DW, 2014, 'Erythropoiesis stimulating agent resistance', in Advances in Drug Resistance Research, pp. 120 - 135

Badve SV; Hawley CM; Johnson DW, 2013, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Zirapury T; van Eps C; Hawley CM; Badve SV; Johnson DW, 2013, 'An overview of erythropoietin therapy', in Erythropoietin Human Production Potential Uses and Adverse Effects, pp. 31 - 53

Bose B; Badve SV; Johnson DW, 2013, 'Peritoneal transport status: A risk factor for peritoneal dialysis', in Peritoneal Dialysis Types Procedures and Risks Factors, pp. 69 - 94

Badve SV; Hawley CM; Johnson DW, 2012, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Malasingam R; Johnson DW; Badve SV, 2012, 'Association Between Haemoglobin Variability and Clinical Outcomes in Chronic Kidney Disease', in Novel Insights on Chronic Kidney Disease, Acute Kidney Injury and Polycystic Kidney Disease, IntechOpen, http://dx.doi.org/10.5772/37128

Badve SV; Beller E; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2010, 'Interventions for erythropoietin‐resistant anaemia in dialysis patients', in Badve SV (ed.), Cochrane Database of Systematic Reviews, Wiley, http://dx.doi.org/10.1002/14651858.cd006861.pub2

Back to profile page